Login / Signup

Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.

Masashi AndoKazunori HondaWaki HosodaYuki MatsubaraRyosuke KumanishiTaiko NakazawaTakatsugu OgataAkinobu NakataHiroyuki KodamaToshiki MasuishiYukiya NaritaHiroya TaniguchiShigenori KadowakiKei Muro
Published in: International journal of clinical oncology (2023)
The outcome of patients with unfavorable-risk CUP remains to be poor. Site-specific therapy based on IHC is not recommended for all patients with unfavorable-risk CUP.
Keyphrases
  • papillary thyroid
  • end stage renal disease
  • squamous cell
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • stem cells
  • lymph node metastasis
  • squamous cell carcinoma
  • patient reported outcomes
  • cell therapy